Zealand Pharma A/S (CPH:ZEAL)
310.60
-25.40 (-7.56%)
May 13, 2026, 4:59 PM CET
Zealand Pharma Employees
As of December 31, 2025, Zealand Pharma had 501 total employees, including 481 full-time and 20 part-time employees. The number of employees increased by 146 or 41.13% compared to the previous year.
Employees
501
Change
146
Growth
41.13%
Revenue / Employee
16.99M DKK
Profits / Employee
11.76M DKK
Market Cap
23.74B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 501 | 146 | 41.13% | 481 | 20 |
| Sep 30, 2025 | 440 | 142 | 47.65% | 440 | 0 |
| Jun 30, 2025 | 424 | 136 | 47.22% | 424 | 0 |
| Mar 31, 2025 | 385 | 115 | 42.59% | 385 | 0 |
| Dec 31, 2024 | 355 | 102 | 40.32% | 335 | 20 |
| Sep 30, 2024 | 298 | 49 | 19.68% | 298 | 0 |
| Jun 30, 2024 | 288 | 52 | 22.03% | 288 | 0 |
| Mar 31, 2024 | 270 | 50 | 22.73% | 270 | 0 |
| Dec 31, 2023 | 253 | 57 | 29.08% | 253 | 0 |
| Sep 30, 2023 | 249 | 46 | 22.66% | 249 | 0 |
| Jun 30, 2023 | 236 | -1 | -0.42% | 236 | 0 |
| Mar 31, 2023 | 220 | -125 | -36.23% | 220 | 0 |
| Dec 31, 2022 | 196 | -159 | -44.79% | 196 | 0 |
| Sep 30, 2022 | 203 | -143 | -41.33% | 203 | 0 |
| Jun 30, 2022 | 237 | -98 | -29.25% | 237 | 0 |
| Mar 31, 2022 | 345 | 10 | 2.99% | 345 | 0 |
| Dec 31, 2021 | 355 | 26 | 7.90% | 355 | 0 |
| Sep 30, 2021 | 346 | 17 | 5.17% | 346 | 0 |
| Mar 31, 2021 | 335 | 144 | 75.39% | 335 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novo Nordisk | 69,505 |
| Demant | 26,704 |
| Coloplast | 16,983 |
| GN Store Nord | 7,371 |
| Ambu A/S | 5,200 |
| H. Lundbeck | 5,039 |
| Embla Medical | 4,500 |
| Genmab | 2,973 |
Zealand Pharma News
- 5 days ago - Zealand Pharma Launches DKK 1.3 Billion Buyback Plan, Stock Soars - GuruFocus
- 6 days ago - Zealand Pharma Earnings Call Transcript: Q1 2026 - Transcripts
- 6 days ago - Zealand Pharma Launches $200 Mln Share Buyback Program - Nasdaq
- 6 days ago - Zealand Pharma posts smaller-than-expected Q1 loss as obesity drugs advance - Reuters
- 15 days ago - Zealand Pharma Announces Positive Topline Phase 3 Results For Weight-Loss Drug Survodutide - Nasdaq
- 2 months ago - Zealand Pharma Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 2 months ago - Disappointing weight-loss-trial results from Zealand Pharma sends shares tumbling - Market Watch
- 2 months ago - Zealand Pharma slump wipes billions off its value after obesity drug data disappoints - Reuters